calendar

102 catalysts · 29 phase 2 completion · 21 phase 1 completion · 20 phase 1 2 completion · 10 phase 1 initiation · 9 phase 1 2 initiation · 5 filing

★ save view export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

show past →

sort

soonest latest type sponsor alpha

TA: ophthalmology TA: pulmonology TA: oncology clear all

phase 0 trial completion4

fda advisory committee meeting2

constraining patent expiry europe1

phase 0 trial initiation1

therapy area

Week of Apr 27, 2026

2

Apr 30, 2026phase 2 completion90d agoCancer Institute and Hospital Chinese Academy of Medical Sciences — capecitabine (Phase II Trial Completion)capecitabine

Therapy area: Oncology. Indication: Colorectal Cancer

full page →capecitabine →source: globaldata

Apr 30, 2026phase 2 completion90d agoNanfang Hospital of Southern Medical University — adebrelimab (Phase II Trial Completion)adebrelimab

Therapy area: Oncology. Indication: Small-Cell Lung Cancer

full page →adebrelimab →source: globaldata

← prev

page 3 of 3

next →